Tango Therapeutics, Inc. (TNGX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$25.12+$0.4900 (+1.99%) on the dayAs of the close; data may be delayed.
TNGX price, last 12 months
Key stats
- Previous close
- $24.63
- Open
- $25.00
- Day range
- $24.08 – $25.38
- 52-week range
- $6.69 – $34.39
- Volume
- 2.7M
- Avg volume (20 days)
- 2.9M
- Market cap
- $4.2B
Performance
1W+15.5%
1M−1.4%
3M−20.2%
6M+26.5%
YTD+183.5%
1Y+222.1%
vs S&P 500, 1Y+205.3 pts
Technicals and fundamentals
About Tango Therapeutics, Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $4.2B